VIR BIOTECHNOLOGY, INC. (VIR) Social Stream
VIR BIOTECHNOLOGY INC (VIR) Price Targets From Analysts
The tables below show the price targets and recommendations analysts covering VIR.
| Date | Number of Analysts | Highest Target Price | Lowest Target Price | Average Target Price | Current Price | Upside Potential |
|---|---|---|---|---|---|---|
| 2021-11-05 | 5 | $135 | $37 | $75.6 | $10.03 | 653.74% |
| 2021-11-11 | 5 | $135 | $36 | $75.4 | $10.03 | 651.74% |
| 2021-11-30 | 6 | $200 | $36 | $88.4 | $10.03 | 781.36% |
| 2022-01-31 | 6 | $300 | $36 | $108.4 | $10.03 | 980.76% |
| 2022-02-01 | 6 | $300 | $36 | $96.333 | $10.03 | 860.45% |
| 2022-02-25 | 5 | $300 | $36.001 | $106.4 | $10.03 | 960.82% |
| 2022-03-03 | 6 | $300 | $28 | $93.333 | $10.03 | 830.54% |
| 2022-03-30 | 6 | $200 | $28 | $76 | $10.03 | 657.73% |
| 2022-05-09 | 6 | $200 | $28 | $74.2 | $10.03 | 639.78% |
| 2022-05-20 | 6 | $125 | $28 | $59.2 | $10.03 | 490.23% |
| 2022-07-15 | 4 | $125 | $28 | $56 | $10.03 | 458.33% |
| 2022-09-07 | 5 | $125 | $28 | $56.5 | $10.03 | 463.31% |
| 2022-10-31 | 7 | $125 | $15 | $46.833 | $10.03 | 366.93% |
| 2022-11-04 | 7 | $125 | $18 | $46.571 | $10.03 | 364.32% |
| 2022-12-19 | 8 | $125 | $18 | $46.571 | $10.03 | 364.32% |
| 2023-01-04 | 8 | $125 | $18 | $48.5 | $10.03 | 383.55% |
| 2023-02-08 | 8 | $125 | $28 | $50.166 | $10.03 | 400.16% |
| 2023-02-21 | 9 | $125 | $28 | $50.571 | $10.03 | 404.2% |
| 2023-02-24 | 9 | $125 | $25 | $49.857 | $10.03 | 397.08% |
| 2023-03-03 | 9 | $125 | $25 | $52.333 | $10.03 | 421.76% |
| 2023-03-06 | 8 | $100 | $25 | $48.166 | $10.03 | 380.22% |
| 2023-04-03 | 8 | $100 | $25 | $46.142 | $10.03 | 360.04% |
| 2023-04-19 | 8 | $100 | $27 | $45.142 | $10.03 | 350.07% |
| 2023-05-05 | 8 | $100 | $27 | $45 | $10.03 | 348.65% |
| 2023-07-05 | 8 | $100 | $27 | $46.285 | $10.03 | 361.47% |
| 2023-07-21 | 9 | $100 | $15 | $40.875 | $10.03 | 307.53% |
| 2023-08-04 | 9 | $100 | $15 | $36.25 | $10.03 | 261.42% |
| 2023-08-07 | 9 | $95 | $15 | $33.875 | $10.03 | 237.74% |
| 2023-11-02 | 9 | $95 | $14 | $32.75 | $10.03 | 226.52% |
| 2023-11-03 | 9 | $95 | $12 | $32.375 | $10.03 | 222.78% |
| 2023-11-07 | 9 | $95 | $12 | $29.75 | $10.03 | 196.61% |
The Trend in the Analyst Price Target
VIR's average price target has moved down $20.42 over the prior 41 weeks.
Over the past 41 weeks, VIR's average upside potential has been 141.47%.
| Date | Number of Analysts | Highest Target Price | Lowest Target Price | Average Target Price | Share Price | Upside Potential |
|---|---|---|---|---|---|---|
| 2023-02-08 | 8 | 125 | 28 | 50.166 | 27.07 | 85.32% |
| 2023-04-03 | 8 | 100 | 25 | 46.142 | 23.28 | 98.2% |
| 2023-07-21 | 9 | 100 | 15 | 40.875 | 14.35 | 184.84% |
| 2023-08-04 | 9 | 100 | 15 | 36.250 | 13.62 | 166.15% |
| 2023-11-03 | 9 | 95 | 12 | 32.375 | 8.76 | 269.58% |
VIR Broker Recommendations Summary
| Average Broker Rating | Strong Buy | Buy | Hold | Sell | Strong Sell | Analysts Issuing Recs |
|---|---|---|---|---|---|---|
| 1.56 | 6 | 1 | 2 | 0 | 0 | 9 |
The Trend in the Broker Recommendations
Over the past 15 months, VIR's average broker recommendation rating improved by 0.24.
Use the points listed below to better contextualize what this analyst price target and recommendations data data means for investors.
- In terms of how VIR BIOTECHNOLOGY INC fares relative to all US stocks, note that its variance in analysts' estimates is lower than -4126.63% of that group.
- To contextualize these metrics, consider that out of stocks in the mid market cap category, VIR BIOTECHNOLOGY INC's upside potential (average analyst target price relative to current price) is greater than 4025.11% of them.
- In the context of Pharmaceutical Products stocks, VIR BIOTECHNOLOGY INC's average analyst price target is higher than 3026.64% of them.
- VIR BIOTECHNOLOGY INC's number of analysts covering the stock is greater than 1935.06% of stocks in the mid market cap category.
In the Pharmaceutical Products industry, AMRX, OGN, and IMVT are the three stocks most similar to VIR BIOTECHNOLOGY INC regarding the price target and analyst recommendation information presented here.
View All Top Stocks by Price Target
Is VIR a Buy, Hold or Sell? See the POWR Ratings now!